
MSGE Stock Forecast & Price Target
MSGE Analyst Ratings
Bulls say
Madison Square Garden is supported by a high-barrier portfolio of iconic venues in New York and Chicago, giving it scarce real estate-like assets that attract premium concerts, sports, and special events while long-term arena license agreements with the Knicks and Rangers provide recurring revenue through 2055. Demand fundamentals are strong, with live entertainment ex-sports growing about 7.4% CAGR since 2019 and remaining above pre-COVID levels, while MSGE’s 2025-2026 season Broadway data and the broader $70BN+ U.S. market suggest resilient consumer willingness to pay for in-person experiences. Near-term catalysts are also compelling, as FY2026 revenue was about $1.06B with ~$262M EBITDA, FY27 AOI is forecast at $289M, and the 230-show Christmas Spectacular plus Harry Styles’ 30-date residency could drive over $100M in gross ticket revenue and support high-margin growth.
Bears say
Madison Square Garden is viewed negatively because its fundamentals show limited upside from a business already priced at roughly 17x forward AOI, while market share still declined about 11 bps in 2025 and only stabilized through 2027 is expected. The company remains exposed to low attendance, softer event demand, and elevated SG&A on a smaller revenue base, which can compress operating leverage and push AOI below the base case. It also faces structural and company-specific risks, including a -ve CAGR in motion picture theaters, slower accommodation spending recovery to about $18B in 2024 versus roughly $19B pre-COVID, tax exemption scrutiny, and heavy dependence on the Christmas Spectacular and affiliated entities.
This aggregate rating is based on analysts' research of Madison Square Garden Entertainment and is not a guaranteed prediction by Public.com or investment advice.
MSGE Analyst Forecast & Price Prediction
Start investing in MSGE
Order type
Buy in
Order amount
Est. shares
0 shares